SAN FRANCISCO On Sunday, Alnylam, the gene-silencing company that notched one gigantic accomplishment after another over the past five years, set out a plan for the next five years built on yet more… [+1190 chars]
Alnylam charts ambitious five-year plan as sales of key drug miss expectations - statnews.com
Gene-silencing company Alnylam charts ambitious five-year plan as sales of key drug miss expectations.
By:Matthew Herper
Source:STAT
Published:
Related News
business
business
business
Hotels are Getting Rid of Proper Bathroom Doors and Guests are Revolting - The Wall Street Journal
The Wall Street Journal•The Wall Street Journal
Bitcoin, U.S. Dollar Skid, Gold Rallies On 'Sell America' Trade - Investor's Business Daily
U.S. dollar, bitcoin, cryptos fall as President Trump escalates tensions with NATO allies over Greenland control. Gold, silver rally.
Investor's Business Daily
Amazon’s CEO says tariffs are starting to ‘creep into’ pricing - The Verge
Amazon CEO Andy Jassy says consumers are starting to see the impact of Donald Trump’s tariffs now that the supply of products the company and other sellers prebought in early 2025 has “run out.”
The Verge•Emma Roth